In the current study, we sought to determine the serum levels of ADAM6 and PRSS1, novel potential biomarkers with emerging implications in leukemogenesis, in adult patients with de novo acute leukemia compared to apparently healthy subjects. Here, ADAM6 is linked to acute leukemia.